A phase II study of guadecitabine (G) with irinotecan (IRI) vs regorafenib or TAS-102 in metastatic colorectal cancer (mCRC) patients (pts) Meeting Abstract
| Authors: | Lee, V.; Zahurak, M.; Cercek, A.; Verheul, H.; Lenz, H.; Jones, P.; Baylin, S.; Parkinson, R.; Rami, V.; Lilly, E.; Miles, T.; Brown, T.; Ahuja, N.; El Khoueiry, A.; Azad, N. |
| Abstract Title: | A phase II study of guadecitabine (G) with irinotecan (IRI) vs regorafenib or TAS-102 in metastatic colorectal cancer (mCRC) patients (pts) |
| Meeting Title: | 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 138 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2020 Oct 24-25 |
| Meeting Location: | Virtual |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-10-01 |
| Start Page: | S12 |
| Language: | English |
| ACCESSION: | WOS:000582839900024 |
| PROVIDER: | wos |
| DOI: | 10.1016/s0959-8049(20)31096-0 |
| Notes: | Meeting abstract: 22 -- Source: Wos |
